Mintz Levin Bolsters Corporate M&A Practice (San Diego)

We are pleased to announce the placement of Scott Stanton with Mintz Levin. Mr. Stanton joins from Morrison & Forester where he has practiced since 2004. He served as chair of the firm’s global Corporate Practice Group from 2010 – 2013.

Mr. Stanton has significant experience in mergers and acquisitions, securities offerings, corporate governance, and general corporate matters. He serves as primary outside counsel to public and private companies, and regularly represents boards of directors and board committees in complex corporate governance matters. Mr. Stanton has developed a deep expertise in SEC reporting and corporate governance matters that enables him to provide expert and practical advice to a broad range of companies in industries such as software, medical devices, life sciences, semiconductors, consumer goods, insurance and defense.

In the mergers and acquisitions area, Mr. Stanton has special expertise in structuring and negotiating a wide variety of transactions. He has worked on well over a hundred transactions, including public company mergers, tender offers, hostile takeovers and other strategic acquisitions and divestitures. Mr. Stanton’s transactions have ranged in size from less than $5 million to nearly $4 billion in industries such as biometrics, semiconductors, manufacturing, medical devices, life sciences, financial services, software, consumer and defense.

Mr. Stanton has represented, among many others;
Fulgent Genetics, Inc. from formation, through financings and a spin-off and in its initial public offering on the Nasdaq Global Select Market.
Cherokee Inc. in its acquisition of Hi-Tec Sports International, a Netherlands-based leader in sports, outdoor, and work footwear, with products sold in over 110 countries.
Cogent, Inc. continuously from its $250 million IPO in 2004 through its $943 million acquisition.
Mentor Corporation in its $1.12 billion all cash acquisition by Johnson & Johnson through a tender offer.
Inamed Corporation in its $3.4 billion merger with Allergan Inc.

Emerging Companies Partner Joins Perkins Coie (Silicon Valley)
Prominent IP Litigation Partner Joins Orrick (San Francisco)